Immunotherapy Could Fill Unmet Need in Leptomeningeal Metastases ...Middle East

Medscape - News
Immunotherapy with pembrolizumab holds promise for improving the generally dismal outlook in patients with leptomeningeal metastases, a phase 2 trial suggests. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy Could Fill Unmet Need in Leptomeningeal Metastases )

Apple Storegoogle play

Also on site :